Mount Sinai specialists debut AI and machine learning models targeting prediction and screening for severe pregnancy complications using imaging and EMR data at SMFM 2026.
Key Details
- 1AI-assisted tools for diagnosis of severe congenital heart defects from fetal scans presented.
- 2Machine learning models using EMR data can preconceptionally predict placenta accreta spectrum with high sensitivity and specificity.
- 3Novel risk factors for placenta accreta, including anemia, identified by the AI models.
- 4AI is being tested for real-world impact on completion rates of fetal cardiac screening at a prenatal ultrasound center.
- 5Research highlights the strong early evidence and potential clinical value of these AI approaches in maternal-fetal medicine.
Why It Matters
These advances suggest AI and machine learning could become critical in early identification and risk stratification of pregnancy complications, potentially improving prenatal care through better screening and management. This intersection between AI, imaging, and obstetric care exemplifies the growing clinical utility of radiology/AI collaboration.
Source
EurekAlert
Related News
•EurekAlert
AI Pathology Tool SÉMIL Improves Stage II Bowel Cancer Risk Assessment
A La Trobe University-developed AI tool accurately predicts relapse risk in stage II bowel cancer using digital pathology images and descriptions.
•EurekAlert
AI Tool Predicts Which Rectal Cancer Patients Benefit from Intensive Therapy
UCL researchers developed an AI that analyzes biopsy slides to identify rectal cancer patients who benefit from adding irinotecan to standard chemoradiotherapy.
•EurekAlert
AI-Guided Handheld Cardiac Ultrasound Reduces Referrals and Costs in Spain
AI-guided handheld cardiac ultrasound enables primary care physicians to detect heart failure, reducing specialist referrals and saving costs.